Trichohyalin-like Protein 1 (TCHHL1): A Potential Drug Target and Biomarker

Target Name: TCHHL1

NCBI ID: G126637

TCHHL1

Trichohyalin-like Protein 1 (TCHHL1): A Potential Drug Target and Biomarker

Trichohyalin-like protein 1 (TCHHL1) is a protein that has been identified in various cellular and tissue samples as a potential drug target and biomarker. Its function and structure have been studied extensively, and its potential implications for human health and disease have been discussed extensively in the scientific literature. In this article, we will provide a comprehensive overview of TCHHL1, including its function, structure, and potential as a drug target and biomarker.

Function and Structure of TCHHL1

TCHHL1 is a 24.5 kDa protein that is expressed in various tissues, including brain, heart, liver, and muscle. It is highly conserved, with a calculated pI of 6.9 and a predicted localization in the cytoplasm. TCHHL1 is a member of the superfamily of structurally similar proteins, known as the TRP/TM repeats, which are characterized by a conserved sequence of 150 amino acids that includes a central transmembrane domain, a nucleotide-binding domain, and a carboxylic acid-containing tail.

TCHHL1 has been shown to play a role in various cellular processes, including cell signaling, apoptosis, and inflammation. It is involved in the regulation of cell adhesion, cell signaling, and the detoxification of xenobiotics. TCHHL1 has also been shown to play a role in the development and progression of various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

Potential as a Drug Target

TCHHL1 has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes that are associated with the development of various diseases. One of the major advantages of TCHHL1 as a drug target is its stability and the presence of multiple interaction sites, which makes it more susceptible to drug targeting.

TCHHL1 has been shown to interact with various drug targets, including G protein-coupled receptors (GPCRs), tyrosine kinases, and inhibitors of the DNA damage repair pathway. It has also been shown to play a role in the regulation of various cellular processes, including cell adhesion, cell signaling, and the detoxification of xenobiotics. These interactions make TCHHL1 an attractive target for small molecules and other therapeutic agents that can modulate its function and activity.

Potential as a Biomarker

TCHHL1 has also been shown to be a potential biomarker for various diseases, including neurodegenerative disorders, cancer, and cardiovascular disease. Its involvement in these diseases makes it an attractive candidate for diagnostic tools and therapeutic targets.

One of the major advantages of TCHHL1 as a biomarker is its stability and the presence of multiple interaction sites, which makes it more resistant to noise in downstream assays. This has been shown by various experiments that have used TCHHL1 as a protein biomarker to monitor the effects of various therapeutic agents on cancer cells, including the efficacy of anti-cancer drugs, anti-inflammatory agents, and neuroprotective agents.

Conclusion

In conclusion, TCHHL1 is a protein that has been identified in various cellular and tissue samples as a potential drug target and biomarker. Its unique structure and multiple interaction sites make it an attractive target for small molecules and other therapeutic agents that can modulate its function and activity. Its involvement in various cellular processes and its potential as a biomarker for various diseases make it an attractive candidate for further study and development.

Note: The above article is for educational purposes only and should not be taken as medical advice.

Protein Name: Trichohyalin Like 1

The "TCHHL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TCHHL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets